Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis

Abstract Background Deworming is one of the strategies to reduce the burden of anemia among pregnant women. Globally, pregnant women in sub-Saharan Africa are more affected by anemia. Therefore, this study examined both the coverage and demographic, socioeconomic, and women empowerment-related facto...

Full description

Bibliographic Details
Main Authors: Betregiorgis Zegeye, Mpho Keetile, Bright Opoku Ahinkorah, Edward Kwabena Ameyaw, Abdul-Aziz Seidu, Sanni Yaya
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Tropical Medicine and Health
Subjects:
DHS
Online Access:https://doi.org/10.1186/s41182-021-00343-x
id doaj-ee93b4fc5e5c4ef8bb4efe01f60d08e2
record_format Article
spelling doaj-ee93b4fc5e5c4ef8bb4efe01f60d08e22021-07-04T11:51:16ZengBMCTropical Medicine and Health1349-41472021-06-0149111510.1186/s41182-021-00343-xUtilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysisBetregiorgis Zegeye0Mpho Keetile1Bright Opoku Ahinkorah2Edward Kwabena Ameyaw3Abdul-Aziz Seidu4Sanni Yaya5HaSET Maternal and Child Health Research Program, Shewarobit Field OfficeDepartment of Population Studies, Faculty of Social Sciences, University of BotswanaSchool of Public Health, Faculty of Health, University of Technology SydneySchool of Public Health, Faculty of Health, University of Technology SydneyDepartment of Population and Health, University of Cape CoastSchool of International Development and Global Studies, Faculty of Social Sciences, University of OttawaAbstract Background Deworming is one of the strategies to reduce the burden of anemia among pregnant women. Globally, pregnant women in sub-Saharan Africa are more affected by anemia. Therefore, this study examined both the coverage and demographic, socioeconomic, and women empowerment-related factors associated with the utilization of deworming medication among pregnant married women in sub-Saharan Africa. Methods We used data from the most recent Demographic and Health Surveys of 26 countries in sub-Saharan Africa conducted between 2010 and 2019. Using Stata version-14 software, analysis was done on 168,910 pregnant married women. Bivariate and multivariable logistic regression analyses were conducted to examine the factors associated with the utilization of deworming medication. The results were presented using adjusted odds ratios (aORs) at 95% confidence intervals (CIs). Results The pooled results showed that about 50.7% (95% CI 48.2–53.3%) of pregnant married women in the studied countries took deworming medications, and this varied from as high as 84.1% in Sierra Leone to as low as 2% in Angola. Regarding sub-regional coverage, the highest and lowest coverages were seen in East Africa (67.6%, 95% CI 66.0–69.1%) and West Africa (24.3%, 95% CI 22.4–26.4%) respectively. We found higher odds of utilization of deworming medication among older pregnant married women (aOR=1.93, 95% CI 1.32–2.84), women with educated husbands (aOR=1.40, 95% CI 1.11–1.77), wealthier women (aOR=3.12, 95% CI 1.95–4.99), women exposed to media (aOR=1.46, 95% CI 1.18–1.80), and those who had four or more antenatal care visits (aOR=1.51, 95% CI 1.24–1.83). Conclusions Enhancing women’s education, disseminating information about maternal healthcare services through mass media, and ensuring that women from economically disadvantaged households benefit from national economic growth can be considered as deworming medication improvement strategies in sub-Saharan Africa. Moreover, providing more attention to adolescents or young pregnant women and increasing the number of antenatal care visits could be considered to increase deworming uptake among pregnant married women.https://doi.org/10.1186/s41182-021-00343-xDewormingDHSFactorsGlobal healthPregnant womenSub-Saharan Africa
collection DOAJ
language English
format Article
sources DOAJ
author Betregiorgis Zegeye
Mpho Keetile
Bright Opoku Ahinkorah
Edward Kwabena Ameyaw
Abdul-Aziz Seidu
Sanni Yaya
spellingShingle Betregiorgis Zegeye
Mpho Keetile
Bright Opoku Ahinkorah
Edward Kwabena Ameyaw
Abdul-Aziz Seidu
Sanni Yaya
Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
Tropical Medicine and Health
Deworming
DHS
Factors
Global health
Pregnant women
Sub-Saharan Africa
author_facet Betregiorgis Zegeye
Mpho Keetile
Bright Opoku Ahinkorah
Edward Kwabena Ameyaw
Abdul-Aziz Seidu
Sanni Yaya
author_sort Betregiorgis Zegeye
title Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
title_short Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
title_full Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
title_fullStr Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
title_full_unstemmed Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis
title_sort utilization of deworming medication and its associated factors among pregnant married women in 26 sub-saharan african countries: a multi-country analysis
publisher BMC
series Tropical Medicine and Health
issn 1349-4147
publishDate 2021-06-01
description Abstract Background Deworming is one of the strategies to reduce the burden of anemia among pregnant women. Globally, pregnant women in sub-Saharan Africa are more affected by anemia. Therefore, this study examined both the coverage and demographic, socioeconomic, and women empowerment-related factors associated with the utilization of deworming medication among pregnant married women in sub-Saharan Africa. Methods We used data from the most recent Demographic and Health Surveys of 26 countries in sub-Saharan Africa conducted between 2010 and 2019. Using Stata version-14 software, analysis was done on 168,910 pregnant married women. Bivariate and multivariable logistic regression analyses were conducted to examine the factors associated with the utilization of deworming medication. The results were presented using adjusted odds ratios (aORs) at 95% confidence intervals (CIs). Results The pooled results showed that about 50.7% (95% CI 48.2–53.3%) of pregnant married women in the studied countries took deworming medications, and this varied from as high as 84.1% in Sierra Leone to as low as 2% in Angola. Regarding sub-regional coverage, the highest and lowest coverages were seen in East Africa (67.6%, 95% CI 66.0–69.1%) and West Africa (24.3%, 95% CI 22.4–26.4%) respectively. We found higher odds of utilization of deworming medication among older pregnant married women (aOR=1.93, 95% CI 1.32–2.84), women with educated husbands (aOR=1.40, 95% CI 1.11–1.77), wealthier women (aOR=3.12, 95% CI 1.95–4.99), women exposed to media (aOR=1.46, 95% CI 1.18–1.80), and those who had four or more antenatal care visits (aOR=1.51, 95% CI 1.24–1.83). Conclusions Enhancing women’s education, disseminating information about maternal healthcare services through mass media, and ensuring that women from economically disadvantaged households benefit from national economic growth can be considered as deworming medication improvement strategies in sub-Saharan Africa. Moreover, providing more attention to adolescents or young pregnant women and increasing the number of antenatal care visits could be considered to increase deworming uptake among pregnant married women.
topic Deworming
DHS
Factors
Global health
Pregnant women
Sub-Saharan Africa
url https://doi.org/10.1186/s41182-021-00343-x
work_keys_str_mv AT betregiorgiszegeye utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
AT mphokeetile utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
AT brightopokuahinkorah utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
AT edwardkwabenaameyaw utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
AT abdulazizseidu utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
AT sanniyaya utilizationofdewormingmedicationanditsassociatedfactorsamongpregnantmarriedwomenin26subsaharanafricancountriesamulticountryanalysis
_version_ 1721319898182844416